Skip to main content

Advertisement

Table 1 Relationships between miR-629-3p and clinicopathologic factors

From: miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer

Variables miR-629-3p Correlation coefficient P value
Low High
Number of patients (n = 367) % Number of patients (n = 158) %
Age, years      −0.016 0.717
  < 35 48 13.1 24 15.2   
 35–65 291 79.3 121 76.6   
  > 65 28 7.6 13 8.2   
Menopause      0.077 0.077
 No 230 62.7 86 54.4   
 Yes 137 37.3 72 45.6   
T      0.071 0.106
 T1 138 37.6 49 31.0   
 T2 180 49.0 82 51.9   
 T3 32 8.6 17 10.8   
 T4 17 4.6 10 6.3   
N      0.139 0.001
 N0 184 50.1 54 34.1   
 N1 94 25.6 52 32.9   
 N2 44 12.0 26 16.5   
 N3 45 12.3 26 16.5   
TNM stage      0.135 0.002
 I 97 26.4 26 16.5   
 II 165 45.0 68 43.0   
 III 105 28.6 64 40.5   
Grade      0.054 0.218
 I 67 18.3 18 11.4   
 II 141 38.4 67 42.4   
 III 159 43.3 73 46.2   
Ki-67      0.045 0.298
  ≤ 14% 102 27.8 37 23.4   
  > 14% 265 72.2 121 76.6   
LVI      0.241 <0.001
 Negative 326 88.8 109 69.0   
 Positive 41 11.2 49 31.0   
  1. LVI Lymphovascular invasion